Suppr超能文献

通过角膜交联治疗的多微生物耐药性角膜炎

Multiorganism, drug-resistant keratitis treated by corneal crosslinking.

作者信息

Kymionis George D, Kouroupaki Anna I, Liakopoulos Dimitrios A, Arandjelovic Ivana R, Tsoulnaras Konstantinos I

机构信息

Vardinoyannion Eye Institute of Crete (VEIC), Faculty of Medicine, University of Crete, Heraklion, Crete - Greece.

Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL - USA.

出版信息

Eur J Ophthalmol. 2016 Jul 1;26(4):e67-e70. doi: 10.5301/ejo.5000755. Epub 2016 Jan 22.

Abstract

PURPOSE

To describe a case of multiorganism, drug-resistant keratitis that responded well to corneal crosslinking (CXL) treatment.

METHODS

A 52-year-old man presented to our institute with a 2-month ocular history of infectious keratitis in his right eye, on topical antibacterial, antifungal, and antiprotozoan treatment, and complained of increase in pain, discomfort, and visual deterioration. Slit-lamp examination revealed advanced infectious keratitis (extensive deep corneal infiltrate with perineuritis). Cultural and molecular analysis of obtained corneal specimens demonstrated combined fungal and Acanthamoeba infection; confocal microscopy confirmed Acanthamoeba infection. Intense targeted topical antifungal and antiprotozoan treatment was initiated immediately and 1 month later CXL was performed due to drug resistance of the infection.

RESULTS

Two weeks after CXL treatment, the corneal findings had deteriorated, while a corneal abscess was formed and extended at almost half of the cornea. This was gradually limited and the corneal infiltrate and abscess were eventually decreased. In addition, the symptoms improved.

CONCLUSIONS

Corneal crosslinking could be an effective therapy in the management of advanced infectious keratitis unresponsive to conventional medical treatment.

摘要

目的

描述一例多病原体耐药性角膜炎病例,该病例对角膜交联(CXL)治疗反应良好。

方法

一名52岁男性因右眼感染性角膜炎2个月病史前来我院就诊,一直在接受局部抗菌、抗真菌和抗原虫治疗,现主诉疼痛加剧、不适及视力下降。裂隙灯检查显示为晚期感染性角膜炎(广泛的深层角膜浸润伴神经炎)。对获取的角膜标本进行培养和分子分析,结果显示合并真菌和棘阿米巴感染;共聚焦显微镜检查证实存在棘阿米巴感染。立即开始强化的靶向局部抗真菌和抗原虫治疗,1个月后,由于感染耐药,进行了角膜交联治疗。

结果

角膜交联治疗2周后,角膜情况恶化,形成角膜脓肿,且几乎扩展至角膜的一半。此后脓肿逐渐得到控制,角膜浸润和脓肿最终减轻。此外,症状也有所改善。

结论

角膜交联可能是治疗对传统药物治疗无反应的晚期感染性角膜炎的有效方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验